Delivery Order 75N92018D00001-75N92018F00001
- Not listed
- This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Washington (UW) for the Trans-Omics for Precision Medicine (TOPMed) program's Centralized Omics Resource (CORE). The $3,849,872.50 firm fixed-price delivery order contract has a period of performance through September 22, 2026. The contract is not set aside and represents a component of UW's substantial IDIQ contract with NHLBI for the Multi-Ethnic Study of...
- This is a $3,450,283 firm fixed price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the Department of Health and Human Services, to the University of Washington (UW) to provide DNA methylation services as part of the NHLBI Trans-Omics for Precision Medicine (TOPMed) program. The contract has an ultimate completion date of September 27, 2026. UW, a prominent public research university in Seattle, Washington, is providing specialized biomedical...
- The University of Washington has been awarded a $6.4 million cost-no-fee delivery order against an existing single award indefinite delivery contract with the National Institutes of Health National Heart, Lung and Blood Institute. The delivery order is for TOPMED DATA STAGE SUPPORT AND TOPMED AWS MIGRATION TO GOOGLE, providing data migration and support services through May 16, 2024. The underlying IDIQ, valued at $500 million over 10 years beginning in September 2023, is for Centralized Omics...
- This is a $13,667,185.62 cost-reimbursement delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the University of Washington (UW) to provide core operations and coordinating center services for the Multi-Ethnic Study of Atherosclerosis (MESA) program. The contract includes tasks such as annual follow-up of cohort members, clinical endpoints ascertainment, study coordination, database and biospecimen repository maintenance, and data analysis. This...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $4.7 million delivery order to the University of Washington to provide centralized omics resources focusing on DNA methylation analysis as part of the Trans-Omics for Precision Medicine (TOPMed) program. This firm fixed-price contract, awarded on September 23, 2024, will be performed in Seattle, Washington, with an ultimate completion date of September 22, 2026. The award represents a non-set-aside competitive procurement that...
- This is a firm-fixed price delivery order under the "MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)III- COORDINATING CENTER" contract, awarded by the National Heart Lung and Blood Institute (NHLBI) to the University of Washington. The $19,824,860.60 award has an ultimate completion date of August 14, 2019 and covers research coordination services for the MESA study, a large-scale cardiovascular disease research initiative. There is no set-aside designation for this contract. The...
- This federal contract award is for the Multi-Ethnic Study of Atherosclerosis (MESA) Coordinating Center (CC) - Task Area B Exam 7, awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the University of Washington (UW). The $1,439,878.05 delivery order contract has an ultimate completion date of March 29, 2024 and is not set aside. UW, a prominent public research university, will provide centralized omics resource DNA methylation services to support research on atherosclerosis...
- This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to the University of Washington (UW) for the Multi-Ethnic Study of Atherosclerosis (MESA) III Coordinating Center. The $4,567,142.81 contract is a delivery order under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a total potential value of $500 million that runs through December 2034. The MESA program is a long-term research study...
- This is a prime federal contract award from the National Heart Lung and Blood Institute, a subcomponent of the Department of Health and Human Services, to the University of Washington (UW). The $11,349,244.46 cost-plus-award-fee contract is for the Laboratory Centers for DNA Re-sequencing & Genotyping Program, which provides specialized research and laboratory services. The contract is not set aside for small businesses. UW is a large public research university that frequently secures...
- The University of Washington has been awarded a delivery order valued at $34.7 million under the Multi-Ethnic Study of Atherosclerosis (MESA) – Task Area A, with an ultimate completion date of December 18, 2034. Funded by the National Heart, Lung, and Blood Institute (NHLBI), this cost-reimbursable contract with no fee component represents a non-set-aside award. The work will be performed at the University of Washington's Seattle campus through its Office of Sponsored Programs division. MESA...
- 75N92018D00001Indefinite Delivery Contract
- 75N92018D00001-75N92018F00001Delivery Order
This is a $11,182,823.59 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Washington (UW) to serve as the Trans-Omics for Precision Medicine (TOPMed) Data Coordinating Center (DCC). The contract involves providing data coordination, specimen processing and distribution, quality control, and information management services to support research on atherosclerosis across diverse populations. The contract is not set aside and is part of a larger $500 million single-award indefinite delivery/indefinite quantity (IDIQ) contract that UW holds with NHLBI for the Multi-Ethnic Study of Atherosclerosis (MESA) program. This long-term commitment by NHLBI highlights UW's expertise in advanced biomedical research and data management. The contract has a period of performance through September 30, 2021.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Trans-Omics for Precision Medicine (TOPMed) Data Coordinating Center (DCC) | HHSN26817HV00001R | Department of Health and Human Services National Institutes of Health | Award Notice 1/3 | 10/13/16, 4:10 PM | |
Trans-Omics for Precision Medicine (TOPMed) Data C | HHSN26817HV00001R | Department of Health and Human Services National Institutes of Health | Award Notice 2/3 | 12/8/16, 10:19 AM | |
Trans-Omics for Precision Medicine (TOPMed) Data C | HHSN26817HV00001R | Department of Health and Human Services National Institutes of Health | Award Notice 3/3 | 5/2/18, 9:45 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00010 | Funding Only Action | ($885k) | 9/10/25 | |
| P00009 | Funding Only Action | ($3k) | 3/31/25 | |
| P00008 | Funding Only Action | ($286k) | 12/9/24 | |
| P00007 | Supplemental Agreement for work within scope | $2.0m | 12/30/20 | |
| P00006 | Funding Only Action | $2.0m | 3/27/20 |